The MRC Confidence in Concept (CIC) at UCL Fund 2016

Lead Research Organisation: University College London

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding.  It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.
 
Description Apollo Tx - Trevor Askwith - mesothelioma
Amount £150,000 (GBP)
Organisation Apollo Therapeutics 
Sector Private
Country United Kingdom
Start 09/2019 
End 09/2020
 
Description BRC Cardiovascular Diseases Theme - Richard Angell
Amount £29,536 (GBP)
Organisation University College Hospital 
Sector Hospitals
Country United Kingdom
Start  
 
Description CRUK Pioneer Award - Bart Vanhaesebroeck - PI3K
Amount £200,000 (GBP)
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2019 
End 09/2021
 
Description Developing novel gene therapy technology for treatment of glycine encephalopathy
Amount £365,837 (GBP)
Funding ID 210774/Z/18/Z 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 08/2018 
End 08/2020
 
Description How do the class I PI3K isoforms contribute to reperfusion injury and ischaemic preconditioning?
Amount £198,067 (GBP)
Funding ID PG/16/85/32471 
Organisation British Heart Foundation (BHF) 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2017 
End 09/2020
 
Description LMB/AZ Blue Sky Fund - Angel/Vanhaesebroeck
Amount £200,000 (GBP)
Organisation AstraZeneca 
Sector Private
Country United Kingdom
Start  
 
Description MRC Joint Global health Trials Scheme - Klein - preterm birth risk
Amount £2,540,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2019 
End 09/2024
 
Description Medcity Collaborate 2 Innovate - Counsell - Lenti viral Technology
Amount £99,926 (GBP)
Organisation MedCity 
Sector Public
Country United Kingdom
Start 09/2019 
End 09/2020
 
Description Proximity-2-Discovery - Richard Angell
Amount £24,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start  
 
Description UCL HEIF - Counsell - Lenti Viral technology
Amount £20,000 (GBP)
Organisation Higher Education Innovation Funding (HEIF) 
Sector Public
Country United Kingdom
Start 09/2018 
End 04/2019
 
Description UCL Knowledge and Innovation Fund - Richard Angell
Amount £24,000 (GBP)
Organisation Higher Education Innovation Funding (HEIF) 
Sector Public
Country United Kingdom
Start  
 
Description UCL Technology Fund - Counsell -Lenti viral technology
Amount £113,424 (GBP)
Organisation UCL Business 
Sector Private
Country United Kingdom
Start 09/2018 
End 09/2019
 
Description Wellcome Trust Innovator Award -Claire Roddie T-cell therapies
Amount £500,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2019 
End 09/2022
 
Description Wellcome trust infectious and immunity PhD programme, Cambridge - Matthew Reeves
Amount £150,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start